Skip to main content
Clinical Trials/NCT00583271
NCT00583271CompletedNot Applicable

A Prospective Study of Endoscopic Ultrasound-guided Celiac (CB) Effectiveness

Indiana University1 site in 1 country127 target enrollmentStarted: June 2002Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
127
Locations
1

Study Overview

Brief Summary

The purpose of this prospective study is to measure the clinical effectiveness of EUS-guided CB in subjects, 50 who have chronic pancreatitis and 50 who have pancreatic cancer, that are already undergoing celiac block for clinical reasons.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients with chronic abdominal pain from documented chronic pancreatitis or pancreatic cancer or other visceral malignancy that are undergoing EUS-guided CB (for purposes other than this study) will be eligible to participate in this study.
  • Patients with chronic pancreatitis and pancreatic cancer must have documented disease by CT, ERCP, or EUS.
  • No evidence of dementia or altered mental status that would prohibit the giving and understanding of informed consent, and no evidence of psychiatric risk that would preclude adequate compliance with this protocol.
  • Patient must provide signed written informed consent

Exclusion Criteria

  • Patients that have had a previous celiac plexus block are eligible for this study

Arms & Interventions

2

subjects who are getting a celiac block for pancreatic cancer

Intervention: 98% dehydrated alcohol (Drug)

1

subjects who are getting a celiac block for chronic pancreatitis

Intervention: triamcinolone (Drug)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

A Prospective Study of EUS Guided Celiac... | Clinical Trial